ClinicalTrials.Veeva

Menu

A Study to Derive Normative Distribution of CIMT and to Determine Its Correlation With Cardiovascular Risk Factors (Score-India)

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Carotid Intima- Media Thickness

Study type

Observational

Funder types

Industry

Identifiers

NCT01551875
Score-India
NIS-CIN-XXX-2011/2

Details and patient eligibility

About

This non-interventional, prospective, multi-centric, cross-sectional study is aimed to obtain the distribution of measurements of CIMT in Indian subjects and will involve approx. 30 investigative sites from all over the country. Each investigative site will be expected to enrol 50 subjects and Carotid intima-media thickness (CIMT) values will be taken for each individual as described in the protocol.

All the procedures could be completed in a single day, however due to any reason any study variable is not taken subject may be asked to come back for a second visit within 7 days of the first visit.

Full description

A Study to derive normative distribution of CIMT and to determine its cOrrelation with cardiovascular Risk factors in asymptomatic nationwidE Indian population. (SCORE India)

Enrollment

1,200 patients

Sex

All

Ages

30+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Provision of subject informed consent
  • Female or male aged 30 years and over

Exclusion criteria

  • Subjects with established cardiovascular event
  • Intake of lipid lowering drug in the past 3 month
  • Subjects with known hypersensitivity to carotid bulb
  • Pregnant or lactating women

Trial design

1,200 participants in 1 patient group

subjects who are meeting the inclusion criteria

Trial contacts and locations

24

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems